Equities

Dicot Pharma AB

Dicot Pharma AB

Actions
  • Price (SEK)0.2285
  • Today's Change0.007 / 2.93%
  • Shares traded1.69m
  • 1 Year change+107.12%
  • Beta1.5087
Data delayed at least 15 minutes, as of Nov 22 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Dicot AB is a manufacturer of pharmaceutical preparation. The Company is located in Uppsala, Sweden.

  • Revenue in SEK (TTM)212.09k
  • Net income in SEK-52.66m
  • Incorporated2015
  • Employees3.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Lipidor AB87.00k-13.53m97.20m----5.78--1,117.26-0.1505-0.15050.00090.02070.005--0.1843---77.12-59.41-178.11-75.10-----15,550.58-643.36----0.00--73.33-20.3372.24------
Pila Pharma AB1.03m-6.92m120.17m0.00--40.93--116.22-0.3165-0.31650.0490.10820.2602--8.211,034,020.00-174.06-108.88-276.40-121.45-406.94-42.67-668.94-1,577.64---163.350.00---22.21--62.92------
Corline Biomedical AB14.01m-9.63m141.84m14.00--1.68--10.13-0.4482-0.44820.65183.930.1456--6.121,077,462.00-10.01-5.71-10.80-6.24137.11128.60-68.77-38.46---740.000.00--6.2874.14-177.67--62.51--
Vivesto AB0.00-98.92m150.38m4.00--0.8398-----0.1839-0.18390.000.33280.00----0.00-39.70---43.32--------------0.00---100.00--64.80------
Enorama Pharma AB5.87m-41.41m233.43m5.00--6.02--39.77-0.9211-0.92110.12950.64080.14131.202.941,173,800.00-99.66-73.56-147.35-104.85-32.7143.36-705.54-557.422.00-29.360.0094---80.17-23.71-6.15------
Orexo AB595.80m-105.30m326.28m113.00------0.5476-3.05-3.0517.28-0.78960.76091.172.325,136,207.00-13.45-6.41-20.81-9.9988.2886.76-17.67-11.831.47-0.75571.05--2.32-3.9927.76--25.77--
Lipum AB (publ)0.00-39.24m362.73m5.00--7.60-----3.17-3.170.002.250.00----0.00-92.41-127.85-120.33-184.50-------293,228.70---328.750.1979------2.38------
Dicot Pharma AB212.09k-52.66m394.89m3.00--2.98--1,861.89-0.052-0.0520.00020.07440.00229.450.072770,696.66-55.17---59.55---21,705.50---24,829.54--15.92--0.00--89.43---39.05------
Enzymatica AB (publ)44.25m-53.96m422.36m17.00--1.98--9.55-0.2956-0.29560.24130.87820.25161.264.342,458,278.00-30.68-27.36-32.09-33.9866.3565.08-121.95-66.12---22.700.0131--4.00-0.638227.57--7.02--
Navamedic ASA542.95m24.62m471.13m45.0019.141.9111.830.86771.391.3931.3014.001.083.604.2112,077,510.004.910.0397.350.063540.0438.334.530.0380.87533.630.3686--33.9822.72-88.77-2.5359.60--
Isofol Medical AB (publ)0.00-39.30m483.74m4.00--5.31-----0.2477-0.24770.000.56370.00----0.00-30.21-66.73-35.26-88.27-------1,023.62----0.00---94.37--76.80------
Infant Bacterial Therapeutics AB0.00-144.03m489.48m9.00--2.48-----10.68-10.680.0015.150.00----0.00-46.02-16.11-52.37-16.69------------0.00-------88.03------
Data as of Nov 22 2024. Currency figures normalised to Dicot Pharma AB's reporting currency: Swedish Krona SEK
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.